US EditionBreakthrough stem cell therapy repairs cornea damage once deemed untreatable
- A new stem cell therapy has repaired cornea damage in 93% of patients in an early clinical trial.
- The therapy restored the cornea in half of participants within three months, and about 90% achieved some recovery after 18 months.
- Dr. Ula Jurkunas stated that the treatment is more than 90% effective at restoring the cornea's surface.
- Researchers plan further trials to seek federal approval, aiming to treat patients with damage to both eyes.
28 Articles
28 Articles
Breakthrough stem cell therapy repairs cornea damage once deemed untreatable
Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study shows. The cornea -- the clear outermost layer of the eye -- can become irreversibly damaged if i
Exclusive | ‘Blue zone’ cruise ship has genetic testing, nutritionists and stem cell therapy — but you have to buy a $1M+ cabin on board
The residential cruise ship from Storylines aims to become the world’s first "blue zone" at sea by taking a holistic approach to residents' health, wellness and longevity.
Novel stem cell therapy repairs 'irreversible' corneal damage in clinical trial
Results from a phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 patients treated and tracked for 18 months had a more than 90% success rate at restoring the cornea's surface and improvements in vision. The procedure, called CALEC (cultivated autologous limbal epithelial cells) involves taking stem cells from a healthy eye, expanding it into a graft over several weeks, then transplanting it into a patient's dam…
Coverage Details
Bias Distribution
- 55% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
